Answers:
It is possible, but significantly unlikely...
this excerpt is taken from a medical treatise on the drug at the website also programmed.
Other Events Observed During the Clinical Development and Postmarketing Experience of Bupropion: In adding together to the adverse events noted above, the following events enjoy be reported within clinical trials and postmarketing experience near the sustained-release formulation of bupropion in depressed patients and in nondepressed smokers, as all right as surrounded by clinical trials and postmarketing clinical experience beside the immediate-release formulation of bupropion.
Adverse events for which frequencies are provided below occur within clinical trials next to bupropion sustained-release. The frequencies represent the proportion of patients who experienced a treatment-emergent adverse event on at tiniest one moment in time contained by placebo-controlled studies for depression (n = 987) or smoking cessation (n = 1,013), or patients who experienced an adverse event requiring discontinuation of treatment in an open-label surveillance study beside bupropion sustained-release tablets (n = 3,100). All treatment-emergent adverse events are included except those nominated surrounded by Tables 5 and 6, those events nominated contained by other safety-related section of the insert, those adverse events subsumed lower than COSTART language that are any overly standard or excessively specified so as to be uninformative, those events not justifiably associated next to the use of the drug, and those events that be not serious and occur contained by a reduced amount of than 2 patients.
Events are further categorized by body system and scheduled surrounded by proclaim of decreasing frequency according to the following definition of frequency: Frequent adverse events are defined as those occurring in at lowest possible 1/100 patients. Infrequent adverse events are those occurring in 1/100 to 1/1,000 patients, while special events are those occurring in smaller amount than 1/1,000 patients.
Adverse events for which frequencies are not provided occur within clinical trials or postmarketing experience near bupropion. Only those adverse events not previously planned for sustained-release bupropion are included. The extent to which these events may be associated beside ZYBAN is unknown.
Body (General): Frequent be asthenia, confusion, and headache. Infrequent be spinal column niggle, chills, inguinal hernia, musculoskeletal chest distress, throbbing, and photosensitivity. Rare be malaise. Also observed be arthralgia, myalgia, and confusion next to unthinking and other symptoms suggestive of delayed hypersensitivity. These symptoms may resemble serum sickness (see PRECAUTIONS).
Cardiovascular: Infrequent be flushing, migraine, postural hypotension, stroke, tachycardia, and vasodilation. Rare be syncope. Also observed be cardiovascular disorder, complete AV block, extrasystoles, hypotension, hypertension (in some cases severe, see PRECAUTIONS), myocardial infarction, phlebitis, and pulmonary embolism.
I'm not decipherable beside the faddy drug but strokes are across the world cause by long possession damgages to the effect vascular structure. The Buproprion could be the straw that broke the camels final, but it would not be the major make happen.
Possible but not probable as nurse say.
deeply depends on the man' pre-existing conditions (health problems)!
Check:
http://www.nlm.nih.gov/medlineplus/drugi...